Current concepts of pain management for cancer patients

Yin Hsun Feng, Ying Wai Wang, Sai Ching Jim Yeung

    Research output: Contribution to journalReview articlepeer-review

    3 Scopus citations

    Abstract

    Pain management is one of the most important issues confronted when treating patients with malignant diseases. Since its release/publication in 1986, the World Health Organization's three-step analgesic ladder has helped to greatly improve pain management in cancer patients. However, many questions about this three-step analgesic ladder have been raised and its application in the clinical setting remains a controversial subject. This review article explores the frontline treatment of cancer pain with morphine and the different routes of fentanyl administration used in cancer pain management. The combination of multiple opiates/opioids has been shown to result in more effective cancer pain management; however, the exact benefits of such opiate/opioid combinations have yet to be established. This article also discusses recent advances in the topical application of morphine and in the combination of ketamine and morphine. It explores the updated treatment principles of neuropathic pain in advanced-stage cancer patients, which incorporate the use of anti-depressants, anti-convulsants, and opioids. Finally, this article reviews the available data and clarifies the general principles for using opioids in cancer patients with renal insufficiency. We hope that this information will be helpful in improving pain management in cancer patients and in facilitating further research.

    Original languageEnglish (US)
    Pages (from-to)154-163
    Number of pages10
    JournalOncology Reviews
    Volume2
    Issue number3
    DOIs
    StatePublished - Sep 2008

    Keywords

    • Cancer pain
    • Opiate
    • Side effect
    • WHO analgesic ladder

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research

    Fingerprint

    Dive into the research topics of 'Current concepts of pain management for cancer patients'. Together they form a unique fingerprint.

    Cite this